Project Grant T32AI200944
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $313K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $201,600 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an Immunology Training Program. The program establishes a collaboration across three Houston-area institutions—Baylor College of Medicine, University of Texas Health Science Center at Houston, and MD Anderson Cancer Center—to train predoctoral immunology researchers. Four carefully selected...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, awarded $571,412 to the University of Maryland, College Park on June 11, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research into the regulation of bacterial physiology and infections through linear diribonucleotides and RNA degradation. The project will characterize how diribonucleases and triribonucleases bind their respective...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Oklahoma Health Sciences Center $233,001 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an interdisciplinary training program in immunity and microbial infection. The award funds a five-year training program that will provide predoctoral research training to five trainees per...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $452,128 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research training in infection and immunity. The award funds the Baylor College of Medicine Research Training in Infection and Immunity program, which will train four MD, MD/PhD, or PhD postdoctoral fellows annually for two years of mentored research training. The program provides a...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded $504,547 to The Regents of the University of California, San Francisco (UCSF) on August 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855, Project Grant T32AI200899). The award funds the UCSF Immunology Training Program (ITP), which provides structured training to approximately 5–6 graduate students per year (3 per cohort) and 2–3...
- The National Institute of Allergy and Infectious Diseases awarded the University of Maryland, Baltimore $127,932 on March 18, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate neuraminidase as a target antigen for a universal influenza virus vaccine. The research addresses the gap between current seasonal influenza vaccines, which elicit only strain-specific immunity with variable effectiveness and provide no protection against novel pandemic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded University of Maryland, Baltimore $136,988 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated biomedical research on Enterovirus D68 (EV-D68) infection mechanisms. The award, obligated on August 20, 2025, with a project completion date of July 31, 2027, supports research designed to advance scientific understanding of how transcription...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $427,625 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore, effective August 1, 2025, through July 31, 2027. This award funds basic biomedical research investigating CD27-mediated immune suppression mechanisms in hematopoietic stem and progenitor cells (HSPCs), innate immune cells, and non-hematopoietic cells. The...
- The National Institute of Allergy and Infectious Diseases awarded the University of Maryland, Baltimore $849,146 on September 9, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on the molecular mechanisms of anthrax toxin unfolding and translocation across host cell membranes. The funded research addresses the biophysical chemistry of how anthrax toxin components—protective antigen, lethal factor, and edema factor—cross cellular endosomal...
- The National Institute of Allergy and Infectious Diseases awarded the University of Maryland, College Park $1,498,706 on April 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to define the cellular and molecular mechanisms of cryptococcal immune reconstitution inflammatory syndrome (IRIS). The recipient will use a novel murine model of Cryptococcus neoformans infection to identify the leukocyte subsets and cytokines mediating lethal cryptococcal IRIS, and to...